Figure 3.
RNA expression of nuclear matrix protein genes identified as significantly downregulated in proteomics analysis for JL DCIS-3 (red bar) and BC stages (blue, pink, and green bars) relative to non-diseased breast reduction (JL-BRL-6) patient-derived cells (gray bar) and to JL-Contra-3 (black bar). These genes manifest no significant difference between JL-BRL-6 (gray bar) and JL-contralateral-3 (black bar; p>0.05). Asterisk (*) denotes that significant different relative to JL-BRL-6 (P<0.05). Pound (#) denotes that significant different relative to JL-contra-3 (P<0.05).